Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy NeoGenomics stock (NEO)

Buy NeoGenomics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

NeoGenomics is a diagnostics & research business based in the US. NeoGenomics shares (NEO) are listed on the NASDAQ and all prices are listed in US Dollars. NeoGenomics employs 2,100 staff and has a trailing 12-month revenue of around $610.7 million.

Our top picks for where to buy NeoGenomics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy NeoGenomics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – NEO. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy NeoGenomics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Finder Score: 4.4 / 5: ★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
Stocks, Options, Mutual funds, ETFs, Alternatives
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
Finder Score: 3.1 / 5: ★★★★★
Stocks, ETFs
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Finder Score: 4.3 / 5: ★★★★★
Stocks, Options, ETFs
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Finder Score: 4.2 / 5: ★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

NeoGenomics stock price (NASDAQ: NEO)

Use our graph to track the performance of NEO stocks over time.

NeoGenomics shares at a glance

Information last updated 2024-07-21.
Latest market close$14.51
52-week range$11.03 - $21.22
50-day moving average $13.95
200-day moving average $15.44
Wall St. target price$20.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.66

Is it a good time to buy NeoGenomics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

NeoGenomics price performance over time

Historical closes compared with the close of $14.51 from 2024-07-19

1 week (2024-07-16) -8.40%
1 month (2024-06-21) 10.17%
3 months (2024-04-23) 2.47%
6 months (2024-01-23) -9.14%
1 year (2023-07-21) -16.80%
2 years (2022-07-22) 53.06%
3 years (2021-07-23) 45.71
5 years (2019-07-23) 23.23

Is NeoGenomics stock undervalued or overvalued?

Valuing NeoGenomics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of NeoGenomics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

NeoGenomics's PEG ratio

NeoGenomics's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.02. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into NeoGenomics's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

NeoGenomics financials

Revenue TTM $610.7 million
Gross profit TTM $187.9 million
Return on assets TTM -3.49%
Return on equity TTM -8.88%
Profit margin -13.79%
Book value $7.25
Market Capitalization $1.9 billion

TTM: trailing 12 months

NeoGenomics share dividends

We're not expecting NeoGenomics to pay a dividend over the next 12 months.

Have NeoGenomics's shares ever split?

NeoGenomics's shares were split on a 1:100 basis on 15 April 2003. So if you had owned 100 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your NeoGenomics shares – just the quantity. However, indirectly, the new 9900% higher share price could have impacted the market appetite for NeoGenomics shares which in turn could have impacted NeoGenomics's share price.

NeoGenomics share price volatility

Over the last 12 months, NeoGenomics's shares have ranged in value from as little as $11.03 up to $21.22. A popular way to gauge a stock's volatility is its "beta".

NEO.US volatility(beta: 1.18)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while NeoGenomics's is 1.18. This would suggest that NeoGenomics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

NeoGenomics overview

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc.

Frequently asked questions

What percentage of NeoGenomics is owned by insiders or institutions?
Currently 1.246% of NeoGenomics shares are held by insiders and 102.664% by institutions.
How many people work for NeoGenomics?
Latest data suggests 2,100 work at NeoGenomics.
When does the fiscal year end for NeoGenomics?
NeoGenomics's fiscal year ends in December.
Where is NeoGenomics based?
NeoGenomics's address is: 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912
What is NeoGenomics's ISIN number?
NeoGenomics's international securities identification number is: US64049M2098
What is NeoGenomics's CUSIP number?
NeoGenomics's Committee on Uniform Securities Identification Procedures number is: 64049M209

More guides on Finder

Ask a question provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site